Intuitive Surgical filings document operating results, governance matters, capital structure, and material events for a Nasdaq-listed medical technology company focused on robotic-assisted surgery. Its Form 8-K reports furnish quarterly and preliminary financial results, procedure information, and exhibits tied to da Vinci and Ion business performance.
Regulatory filings also cover shareholder voting matters, proxy governance, executive compensation, director elections, and officer-role changes. Other material-event disclosures record completed corporate actions, including the acquisition of da Vinci and Ion distribution operations in Europe, alongside formal disclosures about common stock and financial reporting matters.
Intuitive Surgical (ISRG) executive transaction: EVP & Chief Medical Officer Myriam Curet exercised 105 stock options at $229.39 and, on the same day (11/10/2025), sold 105 common shares at $560 under a Rule 10b5-1 trading plan.
Following these transactions, she reported 0 shares held directly, 353 shares held indirectly by a trust, and 1,571 non-qualified stock options remaining outstanding (expiration 02/27/2030).
Intuitive Surgical (ISRG) reported insider activity by EVP & Chief Digital Officer Brian Miller. On 11/10/2025, he exercised options for 1,298 shares at $229.39 and 2,202 shares at $208.90, then sold the same 3,500 shares at $575.00 per share under a Rule 10b5-1 trading plan that expires on December 10, 2025. Following these transactions, he directly owned 5,758 common shares. Remaining derivative holdings included 2,115 and 6,602 non-qualified stock options from prior grants, subject to stated vesting schedules.
Intuitive Surgical (ISRG) reported an insider transaction by its VP Corporate Controller. On 11/05/2025, the officer exercised non-qualified stock options for 1,908 shares at $76.9989 and 159 shares at $59.4622, then sold the same amounts at $550 per share pursuant to a Rule 10b5-1 trading plan. Following these transactions, direct beneficial ownership stood at 473 common shares. The options exercised were granted under the 2010 Incentive Award Plan, with vesting schedules as disclosed.
Intuitive Surgical (ISRG) CEO and Director David J. Rosa reported an insider gift of 5,454 shares of common stock on 11/03/2025, coded G for gift at $0.0 per share. Following the transaction, he directly holds 228,802 shares. The filing notes the shares were gifted to The Rosa Donor Advised Fund.
Intuitive Surgical (ISRG) insider activity: EVP & Chief Medical Officer Myriam Curet reported option exercises and open‑market sales under a Rule 10b5‑1 trading plan. On 10/28/2025, she exercised 5,030 options at $242.3367, 1,153 at $229.39, and 1,379 at $208.9, then sold the corresponding shares at a weighted average price of $548.4254. On 10/29/2025, she exercised 125 options at $208.9 and sold those shares at $543.
After these transactions, direct holdings were 0 shares; indirect holdings were 353 shares held by a trust. Footnotes note the plan expires July 29, 2026 and provide vesting schedules under the company’s 2010 Incentive Award Plan.
Intuitive Surgical (ISRG) insider Gary S. Guthart, Executive Chair and Director, reported insider transactions on 10/24/2025. He exercised 36,000 non-qualified stock options at an exercise price of $109.4856 and sold shares the same day under a prearranged plan.
Dispositions included 28,800 shares at a weighted average price of $547.5571, plus additional sales of 1,400 shares at $546.3499 and 1,400 shares at $546.184. The filing states the trades were made under a Rule 10b5-1 trading plan that expires on April 28, 2026, with sale price ranges and undertakings to provide full breakdowns upon request.
Intuitive Surgical (ISRG): Director transaction disclosed. Director Craig H. Barratt exercised a non-qualified stock option for 2,193 shares at an exercise price of $71.3233 on 10/24/2025 and sold 2,193 shares at $548.01 the same day under a Rule 10b5-1 trading plan.
Following the transactions, direct common stock holdings were 0 shares, and indirect holdings were 27,198 shares held by a trust. The filing also reports 750 derivative securities (options) remaining beneficially owned directly. The trading plan complies with Rule 10b5-1 and expires on April 29, 2026. The option was granted under the Non-Employee Directors' Stock Option Plan with vesting as noted in the plan terms.
Intuitive Surgical (ISRG) CEO David J. Rosa reported insider transactions on 10/24/2025. He exercised 27,000 non-qualified stock options at an exercise price of $79.6378 per share and sold 24,500 shares of common stock at a weighted average price of $547.5502.
The sales were executed under a Rule 10b5-1 trading plan that expires on June 11, 2026, with individual trade prices ranging from $542.16 to $550.21. Following these transactions, Rosa beneficially owns 234,256 shares directly. The exercised option, granted under the 2010 Incentive Award Plan, carries an expiration date of 02/15/2027 and vested per a stated schedule.
Intuitive Surgical (ISRG) reported strong Q3 2025 results. Revenue rose to $2,505.1M from $2,038.1M a year ago, led by instruments and accessories $1,518.8M, systems $590.4M, and service $395.9M. Net income was $704.4M with diluted EPS of $1.95 (vs. $1.56), and income from operations reached $759.7M. U.S. revenue was $1,717.6M; outside the U.S. was $787.5M.
Cash and cash equivalents were $2,806.6M and short‑term investments $2,102.2M as of September 30, 2025. Year‑to‑date cash from operations was $2,138.0M. The company repurchased $1,919.6M of stock in Q3 at an average price of $479.60; authorization remaining was about $1.9B. Remaining performance obligations were $2.88B. Intuitive outlined a pending acquisition of da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, and San Marino for EUR 290M upfront plus up to EUR 31M in milestones, subject to approvals and expected in the first half of 2026.
Legal updates included an appeals court affirming a prior judgment in the Rex Medical matter and a trial court ruling in Intuitive’s favor on SIS antitrust claims; a related class action was certified, with no trial date set.
Intuitive Surgical (ISRG) furnished an 8-K announcing quarterly results. On October 21, 2025, the company issued a press release with financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1. The materials are furnished and not deemed filed under the Exchange Act.